Literature DB >> 7791694

[Factitious disease caused by secret administration of the oral anticoagulant phenprocoumon: study of 16 personal cases].

D Petersen1, M Barthels.   

Abstract

BACKGROUND: It is frequently difficult to disclose covert ingestion of cumarins being the underlying cause of a bleeding disorder. PATIENTS AND METHODS: We report on 16 cases (15 patients) of phenprocoumon (Marcumar) abuse. All patients (9 females, 6 males) were admitted to the hospital because of bleeding and/or prolonged thromboplastin times. Analysis of phenprocoumon in the blood was performed by HPLC. RESULTS AND
CONCLUSIONS: The clinical presentation of the bleeding was highly variable. Thromboplastin times ranged from < 5 to 58%. With the exception of two patients with hepatic dysfunctions factor V activity was normal. All but one patient denied the ingestion of Marcumar. One patient died from hemorrhage. Two types of patients emerge from our series: Type I is the young nurse (8 cases), type II the usually male patient formerly treated with phenprocoumon (5 cases). Type I patients had long medical histories and showed autoaggressive behavior including the artificial manipulation of disorders other than hemorrhage. Thromboplastin times however were within or close to the therapeutic range (10 to 25%). Type II patients did not simulate other diseases in addition to hemorrhage. Thromboplastin times were longer than in type I patients. In all instances discrimination between non suicidal and suicidal behaviour was difficult. Psychiatric consultance is indicated.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7791694

Source DB:  PubMed          Journal:  Med Klin (Munich)        ISSN: 0723-5003


  2 in total

1.  [Successful therapy of phenprocoumon poisoning with plasmapheresis].

Authors:  V Gläser; R Seifert
Journal:  Med Klin (Munich)       Date:  1998-03-15

Review 2.  A guide to acquired vitamin K coagulophathy diagnosis and treatment: the Russian perspective.

Authors:  Valery V Wojciechowski; Daniela Calina; Konstantinos Tsarouhas; Alexander V Pivnik; Alexander A Sergievich; Vladimir V Kodintsev; Ekaterina A Filatova; Eren Ozcagli; Anca Oana Docea; Andreea Letitia Arsene; Eliza Gofita; Christina Tsitsimpikou; Aristidis M Tsatsakis; Kirill S Golokhvast
Journal:  Daru       Date:  2017-04-17       Impact factor: 3.117

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.